169 related articles for article (PubMed ID: 7086834)
1. Synthesis of prostanoids with bicyclo[2.2.1]heptane, bicyclo[3.1.1]heptane, and bicyclo[2.2.2]octane ring systems. Activities of 15-hydroxy epimers on human platelets.
Wilson NH; Peesapati V; Jones RL; Hamilton K
J Med Chem; 1982 May; 25(5):495-500. PubMed ID: 7086834
[TBL] [Abstract][Full Text] [Related]
2. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
[No Abstract] [Full Text] [Related]
3. Synthesis and biological activity of novel carbacyclins having bicyclic substituents on the omega-chain.
Tomiyama T; Wakabayashi S; Yokota M
J Med Chem; 1989 Aug; 32(8):1988-96. PubMed ID: 2666669
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A2 receptor antagonists. II. Synthesis and pharmacological activity of 6,6-dimethylbicyclo[3.1.1]heptane derivatives with the benzenesulfonylamino group.
Seno K; Hagishita S
Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):948-54. PubMed ID: 2527624
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis and antiaggregation activity of prostacyclin analogs. 1. Bicyclo [3.2.0] heptane analogs].
Lopp MI; Miuraus AI; Parve OV; Vialimiaé TK; Lopp AKh
Bioorg Khim; 1988 Feb; 14(2):222-31. PubMed ID: 3289544
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and platelet aggregation inhibition activity of a series of enantiomeric bicyclo[3.2.0]heptane-6-oximinoacetic acids (1).
O-Yang C; Kertesz DJ; Kluge AF; Kuenzler P; Li TT; Marx MM; Bruno JJ; Chang LF
Prostaglandins; 1984 Jun; 27(6):851-63. PubMed ID: 6484210
[TBL] [Abstract][Full Text] [Related]
7. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
[No Abstract] [Full Text] [Related]
8. Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives.
Das J; Vu T; Harris DN; Ogletree ML
J Med Chem; 1988 May; 31(5):930-5. PubMed ID: 2966247
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.
Sprague PW; Heikes JE; Gougoutas JZ; Malley MF; Harris DN; Greenberg R
J Med Chem; 1985 Nov; 28(11):1580-90. PubMed ID: 4067988
[TBL] [Abstract][Full Text] [Related]
10. Studies on prostaglandins. III. Synthesis of bicyclo[4.3.0]nonane derivatives.
Inukai N; Iwamoto H; Tamura T; Yanagisawa I; Ishii Y; Takagi T; Tomioka K; Murakami M
Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1414-7. PubMed ID: 1021296
[No Abstract] [Full Text] [Related]
11. Synthesis of thromboxane receptor antagonists with bicyclo[3.1.0]hexane ring systems.
Kamata S; Haga N; Tsuri T; Uchida K; Kakushi H; Arita H; Hanasaki K
J Med Chem; 1990 Jan; 33(1):229-39. PubMed ID: 2136917
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 receptor antagonists. III. Synthesis and pharmacological activity of 6,6-dimethylbicyclo[3.1.1]heptane derivatives with a substituted sulfonylamino group at C-2.
Seno K; Hagishita S
Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1524-33. PubMed ID: 2528414
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (+/-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo[2.2.1] hept-2-exo-yl]heptenoic acid.
Narisada M; Ohtani M; Watanabe F; Uchida K; Arita H; Doteuchi M; Hanasaki K; Kakushi H; Otani K; Hara S
J Med Chem; 1988 Sep; 31(9):1847-54. PubMed ID: 2970551
[TBL] [Abstract][Full Text] [Related]
14. Diphenylmethylazine prostanoids with prostacyclin-like actions on human platelets.
Jones RL; Wilson NH; Marr CG; Muir G; Armstrong RA
J Lipid Mediat; 1993; 6(1-3):405-10. PubMed ID: 8357998
[TBL] [Abstract][Full Text] [Related]
15. Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists.
Misra RN; Brown BR; Sher PM; Patel MM; Hall SE; Han WC; Barrish JC; Kocy O; Harris DN; Goldenberg HJ
J Med Chem; 1993 May; 36(10):1401-17. PubMed ID: 8496908
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro activity of stereoisomers of a novel thromboxane receptor antagonist, (+-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo [2.2.1]hept-2-exo-yl]heptenoic acid.
Ohtani M; Narisada M
J Med Chem; 1990 Mar; 33(3):1027-31. PubMed ID: 2137879
[TBL] [Abstract][Full Text] [Related]
17. Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationships.
Nakane M; Reid JA; Haslanger MF; Garber DP; Harris DN; Ogletree ML; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():291-3. PubMed ID: 3004140
[No Abstract] [Full Text] [Related]
18. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
19. 11,12-Secoprostaglandins. 5. 8-Acetyl- or 8-(1-hydroxyethyl)-12-hydroxy-13-aryloxytridecanoic acids and sulfonamide isosteres as inhibitors of platelet aggregation.
Bicking JB; Jones JH; Holtz WJ; Robb CH; Kuehl FA; Minsker DH; Cragoe EJ
J Med Chem; 1978 Oct; 21(10):1011-8. PubMed ID: 214552
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective synthesis of bicyclo[3.1.1]heptane derivatives via intramolecular photocycloaddition reaction.
Honda K; Konishi M; Kawai M; Yamada A; Takahashi Y; Hoshino Y; Inoue S
Nat Prod Commun; 2012 Apr; 7(4):459-62. PubMed ID: 22574441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
